MedPath

Isoniazid

ISONIAZID TABLETS, USP

Approved
Approval ID

1247f0c8-25be-49b0-96e1-22b1cf50dc00

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 2, 2012

Manufacturers
FDA

VersaPharm Incorporated

DUNS: 956741896

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Isoniazid

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code61748-013
Application NumberANDA087425
Product Classification
M
Marketing Category
C73584
G
Generic Name
Isoniazid
Product Specifications
Route of AdministrationORAL
Effective DateAugust 12, 2010
FDA Product Classification

INGREDIENTS (6)

ISONIAZIDActive
Quantity: 300 mg in 1 1
Code: V83O1VOZ8L
Classification: ACTIB
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT

Isoniazid

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code61748-016
Application NumberANDA080212
Product Classification
M
Marketing Category
C73584
G
Generic Name
Isoniazid
Product Specifications
Route of AdministrationORAL
Effective DateAugust 12, 2010
FDA Product Classification

INGREDIENTS (6)

ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
ISONIAZIDActive
Quantity: 100 mg in 1 1
Code: V83O1VOZ8L
Classification: ACTIB
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.